Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,295,665
+$72,283 QoQ
Shares Held
3,578
+2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,525
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wellington Shields Capital Management, LLC holds $19,991,464 across 9 Drug Manufacturers - General names. AMGN ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,793 | $11,746,018 | |
| 2 | JNJ |
Johnson & Johnson
|
12,573 | $3,193,164 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,175 | $1,307,487 | |
| 4 | AMGN |
Amgen Inc
This page
|
3,578 | $1,295,665 | |
| 5 | ABBV |
AbbVie Inc.
|
4,721 | $1,187,992 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,407 | $714,891 | |
| 7 | PFE |
Pfizer Inc
|
13,191 | $317,639 | |
| 8 | GSK |
GSK plc
|
3,103 | $162,659 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,295,665 | 3,578 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,223,382 | 3,477 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,140,675 | 3,485 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $982,902 | 3,483 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,000,130 | 3,582 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,185,759 | 3,806 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $991,427 | 237,480 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,224,720 | 3,801 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,186,997 | 3,799 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,051,131 | 3,697 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,100,524 | 3,821 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,040,101 | 3,870 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $858,773 | 3,868 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,007,372 | 4,167 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,119,896 | 4,264 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $960,880 | 4,263 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,061,031 | 4,361 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,139,000 | 90,884 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,384,915 | 6,156 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $1,779,375 | 7,300 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $38,785,995 | 155,886 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,666,920 | 7,250 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $254,160 | 1,000 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $237,275 | 1,006 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $202,730 | 1,000 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||